Literature DB >> 27864214

Vasculitic neuropathy induced by pembrolizumab.

F Aya1,2, V Ruiz-Esquide3, M Viladot1, C Font1, S Prieto-González4, A Prat1,5, A Arance1,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27864214     DOI： 10.1093/annonc/mdw613

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  15 in total

Review 1.  Update on Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Comana Cioroiu; Louis H Weimer
Journal:  Curr Neurol Neurosci Rep       Date:  2017-06       Impact factor: 5.081

Review 2.  Systemic Vasculitis Associated With Immune Check Point Inhibition: Analysis and Review.

Authors:  Teresa M Crout; Day S Lennep; Shweta Kishore; Vikas Majithia
Journal:  Curr Rheumatol Rep       Date:  2019-05-21       Impact factor: 4.592

3.  Diagnosis and Management of Rare Immune-Related Adverse Events.

Authors:  Sara R Schoenfeld; Mary E Aronow; Rebecca Karp Leaf; Michael Dougan; Kerry L Reynolds
Journal:  Oncologist       Date:  2019-11-06

Review 4.  Chemotherapy-induced peripheral neuropathy: A current review.

Authors:  Nathan P Staff; Anna Grisold; Wolfgang Grisold; Anthony J Windebank
Journal:  Ann Neurol       Date:  2017-06-05       Impact factor: 10.422

Review 5.  Neurologic Immune-Related Adverse Events Associated with Immune Checkpoint Inhibition.

Authors:  Peter Chei-Way Pan; Aya Haggiagi
Journal:  Curr Oncol Rep       Date:  2019-11-27       Impact factor: 5.075

6.  Neurological Complications Associated With Anti-Programmed Death 1 (PD-1) Antibodies.

Authors:  Justin C Kao; Bing Liao; Svetomir N Markovic; Christopher J Klein; Elie Naddaf; Nathan P Staff; Teerin Liewluck; Julie E Hammack; Paola Sandroni; Heidi Finnes; Michelle L Mauermann
Journal:  JAMA Neurol       Date:  2017-10-01       Impact factor: 18.302

7.  Vasculitis associated with immune checkpoint inhibitors-a systematic review.

Authors:  Anisha Daxini; Keri Cronin; Antoine G Sreih
Journal:  Clin Rheumatol       Date:  2018-06-19       Impact factor: 2.980

Review 8.  Neuromuscular Complications of Programmed Cell Death-1 (PD-1) Inhibitors.

Authors:  Justin C Kao; Adipong Brickshawana; Teerin Liewluck
Journal:  Curr Neurol Neurosci Rep       Date:  2018-08-04       Impact factor: 5.081

Review 9.  Clinical features, predictive correlates, and pathophysiology of immune-related adverse events in immune checkpoint inhibitor treatments in cancer: a short review.

Authors:  Jennifer M Yoest
Journal:  Immunotargets Ther       Date:  2017-10-10

Review 10.  Vascular toxic effects of cancer therapies.

Authors:  Joerg Herrmann
Journal:  Nat Rev Cardiol       Date:  2020-03-26       Impact factor: 32.419
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.